Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

The French firm will use the proceeds to advance its ALIGATER platform for delivering genetic payloads and move its preclinical assets toward the clinic.

Financing co-led by Novo Holdings A/S and Bpifrance (as part of the InnoBio investment strategy) and joined by leading US and EU investors Invus ...

The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

A single amino acid change in a neuronal ion channel called KCNQ2 blocks ion flow, prevents protein localization on axons, and results in severe epilepsy and slowed neurological development.

research and laboratory facilities." The School has been awarded the prestigious Athena SWAN Gold award in recognition of its work to support women in science.

2.3.2 Preparation of a ready-to-use SPR-Biosensor chip and binding analysis All SPR-based measurements were determined using a Biacore T200 analytical system (Cytiva) with the analysis temperature set ...

In our most popular video, Science News Explores assistant managing editor Maria Temming explains that a high dose of the drug can temporarily scramble a person’s unique default brain activity.

Illustration by Emily Lankiewicz / Full credit at bottom of article Joe Spring and Carlyn Kranking This year, Smithsonian magazine published more than 900 science stories. Most of those appeared ...

Following the open science principle of accessibility, “A Universe of Sound” helps members of the public who are blind or low vision experience NASA data in a new sensory way. Sighted users also enjoy ...

Sai Life Sciences IPO listing: Sai Life Sciences shares made a strong debut on Wednesday, December 18 as they listed at ₹650 on NSE, a premium of 18.4 percent over the issue price of ₹549.